Ava Raises $9.7M in Series A Funding
Summary
Ava, a San Francisco, CA- and Zurich, Switzerland-based medical technology company focused on innovations in women’s reproductive health, raised $9.7m in Series A funding.The round was led by European VC firm Polytech Ecosystem Ventures with participation from new investors Blue Ocean Ventures and Global Sources, existing investors Swisscom and ZKB, etc.Co-founded by Lea von Bidder and Pascal Koenig, Ava provides a bracelet which uses a patented big data approach to detect a woman’s entire fertile window in real time.the FDA-approved medical device works by recording nine physiological factors that correspond with the rise in hormones indicating the onset of ovulation.It was proven in a recently concluded clinical study at the University Hospital of Zurich to detect an average of 5.3 fertile days per cycle with 89% accuracy.